
argenx SE ARGX
€ 591.55
2.75%
Geschäftsbericht 2024
hinzugefügt 14.03.2026
argenx SE P/S 2011-2026 | ARGX
P/S Jährlich argenx SE
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 311 | 79.9 | 178 | 52.4 | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 311 | 52.4 | 155 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Altimmune
ALT
|
7.76 K | $ 3.45 | 3.29 % | $ 304 M | ||
|
Amgen
AMGN
|
5.4 | $ 351.92 | 1.18 % | $ 189 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.73 | $ 19.55 | 0.26 % | $ 914 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.4 | 1.82 % | $ 357 M | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 218.41 | -1.57 % | $ 5 B | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.61 | - | $ 16.4 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Benitec Biopharma
BNTC
|
54.5 | $ 11.01 | 0.27 % | $ 453 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Compugen Ltd.
CGEN
|
49.8 | $ 2.08 | -0.48 % | $ 194 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Coherus BioSciences
CHRS
|
5.36 | $ 1.59 | 4.28 % | $ 186 M | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
10.4 | $ 0.6 | -1.9 % | $ 6.87 M | ||
|
Cellectis S.A.
CLLS
|
6.69 | $ 3.37 | 0.75 % | $ 116 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Cullinan Management
CGEM
|
35.1 | $ 12.91 | 1.33 % | $ 778 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Calithera Biosciences
CALA
|
98.5 | - | -10.95 % | $ 876 K | ||
|
Cara Therapeutics
CARA
|
2.58 | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
0.0564 | - | - | $ 3.74 B | ||
|
CorMedix
CRMD
|
0.00146 | $ 6.32 | 1.12 % | $ 455 K | ||
|
Checkpoint Therapeutics
CKPT
|
3.91 K | - | - | $ 169 M | ||
|
Clovis Oncology
CLVS
|
1.55 | - | -7.23 % | $ 13 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Denali Therapeutics
DNLI
|
7.68 | $ 20.96 | 3.92 % | $ 3.45 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
24.5 | $ 4.26 | 0.35 % | $ 707 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M |